Beckman Coulter, Blueprint Initiative, Eidogen-Sertanty, Lester Crawford, Steven Galson, Janet Woodcock, Natalie Dakers, Connie Eaves, Thomas Hudson, Kelvin Ogilvie, Jacques Simard, Ronald Worton | GenomeWeb

New Products

Beckman Coulter announced last week the addition of new lines of non-human antibodies, cell signaling reagents and multiplex bead assays to the company's existing antibody portfolio. The new products are highlighted in the new Cellular Analysis Catalog which describes over 3,200 products, including 1,800 new animal antibodies and a new menu of MHC tetramers for T-cell research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.